The Society of Breast Imaging (SBI) announced it has canceled its annual symposium with the American College of Radiology due to concerns over the growing COVID-19 outbreak. The meeting had been planned for April 16-19 in Denver.
"Protecting the health and well-being of all attendees is our greatest concern," said SBI President Margarita L. Zuley, M.D., in a written statement. "Canceling the Symposium required much discussion and deep consideration. It was a decision we came to reluctantly."
The organization made its decision after reviewing the World Health Organization's evaluations, as well as the ongoing amount of research being published on the impact of the virus. Full refunds will be made available to all registered attendees over the next few weeks, according to the press announcement.
There are no plans to reschedule the meeting for later this year. Instead, the next meeting is planned for April 8-11, 2021, in Savannah, Ga.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.